top of page
TX.jpg

IN THE STATES

TEXAS

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Texas in 2022.

TX.png

Economic
Output

$95B

Direct Jobs Supported by the Industry

49,165

Total Jobs Supported

309,628

State Total Vendor Relationships

2,455

State Total Vendor Spending

$2,573,397,507

Clinical
Trials

1,989

Investments at Clinical Trial Sites

$1.55B

Clinical Trial Participants

91,696

Total Economic Impact of Clinical Trial Sites

$4.61B

bottom of page